Answers are grounded in this paper and cite their sources.
New regulations challenge the evidence based, benevolent ethos that underlies medical practice In 2018, the International Association of Athletics Federations (IAAF) introduced new eligibility regulations for female athletes with differences of sex development, including those with congenital adrenal hyperplasia, androgen insensitivity syndrome, and 5α-reductase deficiency (box 1).1 The regulations are based on the contention that women with high levels of endogenous testosterone and androgen sensitivity have a performance advantage over their peers. Athletics South Africa and Mokgadi Caster Semenya, the South African runner who won Olympic gold medals in 2012 and 2016, are contesting the legality of the new regulations. Box 1 ### IAAF eligibility regulations for female athletes with differences of sex development1RETURN TO TEXT
No takes yet. Share an insight, caveat, or question.
Tannenbaum et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: